Activity of quinupristin/dalfopristin against Streptococcus pneumoniae in vitro and in vivo in the rabbit model of experimental meningitis

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue SUPPL. A, 1997, Pages 121-127

  Tarasi, Agapito ^a,b   Dever, Lisa L ^a,c   Tomasz, Alexander ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; DALFOPRISTIN; QUINUPRISTIN; STREPTOGRAMIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL MENINGITIS; BACTERICIDAL ACTIVITY; DRUG EFFICACY; EXPERIMENTAL INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RABBIT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTI-BACTERIAL AGENTS; CHINCHILLA; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; MALE; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; RABBITS; STREPTOCOCCUS PNEUMONIAE; VIRGINIAMYCIN;

EID: 0030927892     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.suppl_1.121     Document Type: Article

References (9)

1. Appelbaum, P. C. (1992). Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clinical Infectious Diseases 15, 77-83.
2. Munoz, R., Coffey, T. J., Daniels, M., Dowson, C. G., Laible, G., Casal, J. et al. (1991). Intercontinental spread of a multi-resistant clone of serotype 23F Streptococcus pneumoniae. Journal of Infectious Diseases 164, 302-6.
3. Munoz, R., Musser, J. M., Crain, M., Briles, D. E., Marton, A., Parkinson, A. J., Sorensen, U. & Tomasz, A. (1992). Geographic distribution of penicillin resistant clones of Streptococcus pneumoniae: characterization by penicillin binding protein profile, surface protein A typing and multilocus enzyme analysis. Clinical Infectious Diseases 15, 112-18.
4. Scares, S., Kristinsson, K. G., Musser, J. M. & Tomasz, A. (1993). Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. Journal of Infectious Diseases 168, 158-63.
5. Low, D. E. (1995). Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience. Microbial Drug Resistance 1, 223-34.
6. Jabes, D., Nachman, S. & Tomasz, A. (1989). Penicillin binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci. Journal of Infectious Diseases 159, 16-25.
7. Jacobs, M. R., Mithal, Y., Robins-Browne, R. M., Gaspar, M. N. & Koornhof, H. J. (1979). Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin. Antimicrobial Agents and Chemotherapy 16, 190-9.
8. National Committee for Clinical Laboratory Standards. (1988). Performance Standard for Antimicrobial Disk Susceptibility Tests, M2-T4, 4th edn. National Committee for Clinical Laboratory Standards, Villanova, PA.
9. Dacey, R. G. & Sande, M. A. (1974). Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrobial Agents and Chemotherapy 6, 437-42.